Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lietman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1995
Apparent deficiency of glutathionine in the PBMC's of people with AIDS depends on method of expressionP Barditch-Crovo, V Svobodova, P Lietman
Annals of Internal Medicine|June 1, 1984
Prophylactic acyclovir therapy and herpes simplexR Ambinder, W Burns, P Lietman, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials designP Lietman, R Temple, M Harrington, et al.
The Journal of Pediatrics|October 1, 1971
The hazard of narcotics in the home: accidental ingestion by infants and young childrenL D Robinson, P Kwiterovich, P Lietman, et al.
The Annals of Otology, Rhinology, and Laryngology|January 1, 1986
Reference values for serial vestibular testingL Proctor, R Glackin, H Shimizu, et al.
The Laryngoscope|December 1, 1987
A study of potential vestibulotoxic effects of once daily versus thrice daily administration of tobramycinL Proctor, B Petty, R Thakor, et al.
Clinical Pharmacology and Therapeutics|November 1, 1987
Biologic response (antiviral) to recombinant human interferon alpha 2a as a function of dose and route of administration in healthy volunteersF Witter, F Barouki, D Griffin, et al.
Journal of Clinical Pharmacology|May 20, 1998
A phase I/II evaluation of oral L-2-oxothiazolidine-4-carboxylic acid in asymptomatic patients infected with human immunodeficiency virusP Barditch-Crovo, D Noe, G Skowron, et al.
The Journal of Infectious Diseases|November 1, 1995
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 TeamR H Haubrich, C Flexner, M M Lederman, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1995
Apparent deficiency of glutathionine in the PBMC's of people with AIDS depends on method of expressionP Barditch-Crovo, V Svobodova, P Lietman
Annals of Internal Medicine|June 1, 1984
Prophylactic acyclovir therapy and herpes simplexR Ambinder, W Burns, P Lietman, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials designP Lietman, R Temple, M Harrington, et al.
The Journal of Pediatrics|October 1, 1971
The hazard of narcotics in the home: accidental ingestion by infants and young childrenL D Robinson, P Kwiterovich, P Lietman, et al.
The Annals of Otology, Rhinology, and Laryngology|January 1, 1986
Reference values for serial vestibular testingL Proctor, R Glackin, H Shimizu, et al.
The Laryngoscope|December 1, 1987
A study of potential vestibulotoxic effects of once daily versus thrice daily administration of tobramycinL Proctor, B Petty, R Thakor, et al.
Clinical Pharmacology and Therapeutics|November 1, 1987
Biologic response (antiviral) to recombinant human interferon alpha 2a as a function of dose and route of administration in healthy volunteersF Witter, F Barouki, D Griffin, et al.
Journal of Clinical Pharmacology|May 20, 1998
A phase I/II evaluation of oral L-2-oxothiazolidine-4-carboxylic acid in asymptomatic patients infected with human immunodeficiency virusP Barditch-Crovo, D Noe, G Skowron, et al.
The Journal of Infectious Diseases|November 1, 1995
A randomized trial of the activity and safety of Ro 24-7429 (Tat antagonist) versus nucleoside for human immunodeficiency virus infection. The AIDS Clinical Trials Group 213 TeamR H Haubrich, C Flexner, M M Lederman, et al.
Pageof 1